Balchem 2Q adj EPS $1.49, est. $1.38

Balchem Corporation (NASDAQ: BCPC) reported adjusted earnings per share (EPS) of $1.49 for the second quarter of 2 quarter, exceeding the estimated $1.38 per share. The company’s second-quarter financial results, released on July 31, 2025, showed 1% increase compared to the prior year quarter. GAAP net earnings were $38.3 million, a 4% increase year-over-year, while adjusted EBITDA reached $69.2 million, up 2% from the prior year. Free cash flow for the quarter was $40.7 million, with cash flows from operations totaling $47.3 million. All three of Balchem’s reporting segments contributed to the growth, with Human Nutrition and Health reporting record sales and earnings from operations. The company also announced plans to build a new $36 million micro-encapsulation manufacturing facility in Orange County, NY, which would significantly expand its production capacity. Additionally, the European Commission imposed provisional anti-dumping duties on choline chloride imports from China, effective July 1, 2025.